Although wild-type HER2 rarely induced indolent tumors, d16HER2 generated luminal-like proliferative in situ lesions, which eventually progressed, and p95HER2 prompted the early appearance of invasive cancers characterized by double-positive luminal and basal epithelial cells. The gene discussed is ERBB2; the disease is cancer.